[Vascular Endothelial Growth Factor Expression and Microvessel Density in Stage I-II Non-Small Cell Lung Cancer and Their Prognostic Significances].
Zhi-Hua Zhu,Tie-Hua Rong,Can-Guang Zeng,Qiu-Liang Wu,Yun Ma,Xiao-Ping Huang,Bao-Jiang Li,Peng-Yuan Zhang,Jin-Ming Zhao,Wei Hu,Shi-Yi Zhang,Hui Yu,Guo-Wei Ma,Lan-Jun Zhang,Zhe-Sheng Wen,Jian-Hua Fu,Hao Long
DOI: https://doi.org/10.3969/j.issn.1000-467x.2005.07.020
2005-01-01
Abstract:BACKGROUND & OBJECTIVE:TNM staging system is used widely to predict prognosis of non-small cell lung carcinoma (NSCLC) patients, but patients with the same stage may have very different survivals; better prognostic index is needed. Angiogenesis is considered to be essential for tumor development, progression, and metastasis, but the prognostic impacts of vascular endothelial growth factor (VEGF) and microvessel density (MVD) in NSCLC is controversial. This study was to evaluate the prognostic value of VEGF and MVD in NSCLC.METHODS:VEGF and MVD in 214 specimens of stageI-II NSCLC (20 in stage IA, 137 in stage IB, and 57 in stage IIB) were detected by tissue chip and SP immunohistochemistry. No patient underwent postoperative antitumor treatment.RESULTS:VEGF expression didn't relate to gender, age, blood type, pathologic type, and TNM stage (P0.05). MVD correlated with age and pathologic type (P0.05), but did not relate to gender, blood type, and TNM stage (P0.05). The mean value of MVD was 65.8+/-5.2 in VEGF-low patients, and 67.5+/-2.5 in VEGF-high patients (P0.05). The 5-year survival rate was significantly lower in MVD-high patients than in MVD-low patients (34.5% vs. 60.0%, P=0.013). Furthermore, multivariate Cox regression analysis showed that MVD (P=0.000) was an independent prognostic factor of NSCLC.CONCLUSION:High MVD closely relates to poor prognosis of stageI-II NSCLC.